Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
AbbVie asks Supreme Court to reconsider ruling on attorney-client communication
12 months ago
Pharma
Law
AbbVie CSO Tom Hudson to retire, replaced by medical chief
12 months ago
People
R&D
Arcutis tacks on atopic dermatitis approval for Zoryve cream
Last year
Pharma
FDA+
Six big R&D questions for Pfizer as science chief Dolsten exits
Last year
R&D
Acquired biotech accuses Novartis of letting IL-15 asset 'wither on the vine'
Last year
Pharma
Law
Lilly bests Novo Nordisk in observational study of GLP-1 drugs
Last year
R&D
Pharma
Experts want to make it easier to get RSV vaccines. Did they make it harder instead?
Last year
Pharma
Moderna wins $176M BARDA award to finance bird flu work
Last year
R&D
Pharma
Cassava says two senior employees included in federal probes
Last year
Pharma
Law
Aerovate plans to lay off nearly all employees after trial failure
Last year
People
R&D
EMA's CHMP recommends 10 new drugs as Pierre Fabre overactive bladder med wins approval
Last year
R&D
Pharma
Inside BARDA's multibillion-dollar effort to fund long-shot biotechs for Covid
Last year
Pharma
Coronavirus
Lykos takes another hit as ICER lays out 'insufficient' evidence for MDMA-based treatment
Last year
R&D
Pharma
Updated: CDC expands RSV vaccine recommendations, namely for adults 75 and older
Last year
Pharma
FDA+
Moderna's updated RSV vaccine disappoints with only 50% efficacy
Last year
R&D
Pharma
Lilly becomes the latest pharma to tap OpenAI for help, this time for antibiotic work
Last year
R&D
AI
Korea-based Bridge Biotherapeutics closes Boston office
Last year
Pharma
UK taps Pfizer over hometown GSK to supply RSV vaccine doses
Last year
Pharma
Lykos’ pain is others’ gain as psychedelic biotechs take notes from adcomm vote
Last year
R&D
In Focus
FDA to pharma companies: Using CRO Synapse's studies 'unacceptable'
Last year
Outsourcing
Pharma
Corrected: Emergent sells Baltimore facility for $30M
Last year
Pharma
Manufacturing
Intra-Cellular reports a depression win, setting up future competition with AbbVie's Vraylar
Last year
R&D
Pharma
GSK readies Blenrep's commercial re-launch in the US, and a push in second line
Last year
R&D
Pharma
Aerovate’s stock craters after PAH drug fails Phase 2 study
Last year
Financing
R&D
First page
Previous page
11
12
13
14
15
Next page
Last page